Get Fit Bharat

Tag: Interval

HomeInterval

Uppsala, Sweden, November 19, 2024. The potency drug developer Dicot Pharma, which recently initiated a phase 2a clinical trial and was listed on Nasdaq First North, is intensifying its focus on future commercialization. One measure is strengthening the management team with the appointment of a Chief Business Officer. The international business …

Fornebu, 19th November 2024, Ocean Yield AS (“Ocean Yield” or the “Company”) announces results for the third quarter 2024.  HIGHLIGHTS EBITDA for Q3 2024 was USD 55.9 million and Adjusted EBITDA was USD 94.6 million. Net profit for Q3 2024 was USD 23.2 million.  Strong balance sheet, with an equity ratio …